Chemically-Induced Disorders
7
2
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
GLP-1R Agonist Treatment for Opioid Use Disorder
An Open-Label Trial of Repetitive Transcranial Magnetic Stimulation for Opioid Use Disorder
Study of Structural Imaging
Neuroimmune Dysfunction in Alcohol Use Disorder